tiprankstipranks
Gemini Therapeutics (GMTX)
NASDAQ:GMTX
US Market

Gemini Therapeutics (GMTX) Stock Investors

116 Followers
Based on 596,841 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GMTX
On average, investors allocate 2.27% of their portfolios to GMTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 596,841 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GMTX

3.3%
Last 7
Days
4.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GMTX, out of 596,841 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GMTX Investor Activity

No data currently available
Based on the activity of 11,322 investors who made their portfolios public
The table shows changes in GMTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GMTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Digital Turbine
3.90%
-0.43%
-1.22%
1.51B
Technology
Crispr Therapeutics AG
3.85%
-0.14%
-0.97%
3.18B
Healthcare
BioNano Genomics
4.42%
-0.48%
-1.06%
436.48M
Healthcare
SNDL
4.02%
-0.54%
-2.11%
485.03M
Basic Materials
Novavax
4.24%
-0.69%
-1.17%
873.84M
Healthcare
fuboTV
3.22%
-0.78%
-2.63%
339.86M
Technology
Li Auto
5.01%
+0.10%
+0.86%
18.58B
Consumer Goods
Ginkgo Bioworks Holdings
3.17%
-0.58%
-1.41%
3.28B
Healthcare
Fisker
4.36%
-0.32%
-0.36%
2.18B
Consumer Goods
Peloton Interactive
3.07%
-0.47%
-2.53%
2.75B
Services
Based on the activity of 596,841 active portfolios
Open your Smart Portfolio

GMTX Investor Analysis

GMTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
27.8%
of GMTX holders
are under 35
Average Segment Performance
Average P/E Ratio12.02
Beta4.79
Dividend Yield4.47%
GMTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
55.6%
of GMTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.33
Beta1.07
Dividend Yield5.31%
GMTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
16.7%
of GMTX holders
are over 55
Average Segment Performance
Average P/E Ratio9.37
Beta0.87
Dividend Yield4.78%
Overview of age group and performance of GMTX stock investors
See who invests in GMTX according to age group and performance.

FAQ

How many retail Investors hold GMTX?
<0.1% of TipRanks' retail investors hold GMTX in their portfolios.
    What is GMTX Investor Sentiment?
    GMTX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GMTX in the last 7 days?
      ▲ 3.3% of TipRanks' retail investors changed their holding of GMTX in the last 7 days.
        What percentage of retail investors changed their holding of GMTX in the last 30 days?
        ▲ 4.7% of TipRanks' retail investors changed their holding of GMTX in the last 30 days.
          What is the average age of retail investors who hold GMTX?
          The average age of GMTX Holders is between 35–55.
            What other stocks have GMTX investors also bought?
            GMTX Investors also bought APPS, CRSP, BNGO, SNDL, NVAX, FUBO, LI, DNA, FSR, PTON.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              SEELSeelos Therapeutics
              ARWRArrowhead Pharmaceuticals
              BIOBio-Rad Laboratories
              BRKRBruker
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis